Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |